Is Buying Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Here Good Idea?

May 25, 2018 - By Hazel Jackson

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Logo

The stock of Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) registered a decrease of 2.98% in short interest. EIGR’s total short interest was 289,800 shares in May as published by FINRA. Its down 2.98% from 298,700 shares, reported previously. With 83,200 shares average volume, it will take short sellers 4 days to cover their EIGR’s short positions. The short interest to Eiger Biopharmaceuticals Inc’s float is 4.69%.

The stock decreased 0.76% or $0.1 during the last trading session, reaching $13. About 297,265 shares traded or 125.83% up from the average. Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) has declined 11.57% since May 25, 2017 and is downtrending. It has underperformed by 23.12% the S&P500.

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. The company has market cap of $137.02 million. The Company’s product candidate pipeline includes Lonafarnib for the treatment of hepatitis delta virus infection; PEG-interferon Lambda-1a (Lambda) for HDV infection; Exendin 9-39 for post-bariatric hypoglycemia; and Ubenimex for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. It currently has negative earnings.

More notable recent Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) news were published by: which released: “45 Biggest Movers From Yesterday” on May 25, 2018, also with their article: “Eiger BioPharmaceuticals (EIGR) Prices 3.2M Common Stock Offering at $12.50/Share” published on May 24, 2018, published: “After-Hours Stock Movers 05/23: (BW) (WSM) (SMRT) Higher; (LB) (NTAP) (EIGR) Lower (more…)” on May 23, 2018. More interesting news about Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) were released by: and their article: “Benzinga’s Daily Biotech Pulse: Eiger And Melinta Fall On Offerings, Apellis And Marinus Rise On Bullish Ratings” published on May 24, 2018 as well as‘s news article titled: “12 Stocks To Watch For May 24, 2018” with publication date: May 24, 2018.

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: